KIORA PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
KIORA PHARMACEUTICALS, INC. (KPRX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 288.81 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-07
- KIORA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 165.00K shares, a 33.17% decline year-over-year.
- KIORA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 123.81K shares.
- KIORA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 10.00K shares.
- KIORA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- KIORA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 256.88K shares, a 246.50% increase from fiscal 2024.
- KIORA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 74.14K shares, a 12.73% decline from fiscal 2023.
- KIORA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 84.96K shares, a 8.03% increase from fiscal 2022.
- KIORA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 78.64K shares, a 808.72% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 165.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | 288.81K shares 10-Q · filed 2026-08-07 | 298.81K shares derived: sum of 3 quarters · filed 2026-08-07 | 298.81K shares derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2026-03-31 | 123.81K shares 10-Q · filed 2026-05-08 | 133.81K shares derived: sum of 2 quarters · filed 2026-05-08 | 133.81K shares derived: sum of 3 quarters · filed 2026-05-08 | 380.69K shares derived: sum of 4 quarters · filed 2026-05-08 | |||
| 2025-12-31 | 10.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 10.00K shares derived: sum of 2 quarters · filed 2026-03-25 | 256.88K shares derived: sum of 3 quarters · filed 2026-03-25 | 256.88K shares 10-K · filed 2026-03-25 | |||
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | 246.88K shares derived: sum of 2 quarters · filed 2025-11-07 | 246.88K shares 10-Q · filed 2025-11-07 | 246.88K shares derived: sum of 4 quarters · filed 2026-05-08 | |||
| 2025-06-30 | 246.88K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | 246.88K shares 10-Q · filed 2025-08-08 | 246.88K shares derived: sum of 3 quarters · filed 2026-05-08 | 321.02K shares derived: sum of 4 quarters · filed 2026-05-08 | |||
| 2025-03-31 | 0.00 shares 10-Q · filed 2026-05-08 | 0.00 shares derived: sum of 2 quarters · filed 2026-05-08 | 74.14K shares derived: sum of 3 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 74.14K shares derived: sum of 2 quarters · filed 2026-03-25 | 74.14K shares 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | 74.14K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | 74.14K shares 10-Q · filed 2024-11-08 | |||||
| 2024-06-30 | 0.00 shares 10-Q · filed 2025-08-08 | ||||||
| 2023-12-31 | -679.44K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | -50.94K shares derived: sum of 2 quarters · filed 2025-03-25 | -41.94K shares derived: sum of 3 quarters · filed 2025-03-25 | 84.96K shares 10-K · filed 2025-03-25 | 764.40K shares 10-K · filed 2024-03-25 | ||
| 2023-09-30 | 628.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 637.50K shares derived: sum of 2 quarters · filed 2023-11-09 | 764.40K shares 10-Q · filed 2023-11-09 | 836.52K shares derived: sum of 4 quarters · filed 2024-03-25 | |||
| 2023-06-30 | 9.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 135.90K shares 10-Q · filed 2023-08-08 | 208.03K shares derived: sum of 3 quarters · filed 2024-03-25 | -45.96K shares derived: sum of 4 quarters · filed 2024-03-25 | |||
| 2023-03-31 | 126.90K shares 10-Q · filed 2023-05-09 | 199.03K shares derived: sum of 2 quarters · filed 2024-03-25 | -54.96K shares derived: sum of 3 quarters · filed 2024-03-25 | -54.96K shares derived: sum of 4 quarters · filed 2024-03-25 | |||
| 2022-12-31 | 72.13K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | -181.86K shares derived: sum of 2 quarters · filed 2024-03-25 | -181.86K shares derived: sum of 3 quarters · filed 2024-03-25 | 78.64K shares 10-K · filed 2024-03-25 | |||
| 2022-09-30 | -253.98K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -253.98K shares derived: sum of 2 quarters · filed 2022-11-09 | 6.52K shares 10-Q · filed 2022-11-09 | 8.52K shares derived: sum of 4 quarters · filed 2023-03-23 | |||
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | 260.50K shares 10-Q · filed 2022-08-12 | 262.50K shares derived: sum of 3 quarters · filed 2023-03-23 | 118.79K shares derived: sum of 4 quarters · filed 2023-03-23 | |||
| 2022-03-31 | 260.50K shares 10-Q · filed 2022-07-08 | 262.50K shares derived: sum of 2 quarters · filed 2023-03-23 | 118.79K shares derived: sum of 3 quarters · filed 2023-03-23 | 138.29K shares derived: sum of 4 quarters · filed 2023-03-23 | |||
| 2021-12-31 | 2.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -141.71K shares derived: sum of 2 quarters · filed 2023-03-23 | -122.21K shares derived: sum of 3 quarters · filed 2023-03-23 | 8.65K shares 10-K · filed 2023-03-23 | 345.87K shares 10-K · filed 2022-04-15 | ||
| 2021-09-30 | -143.71K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -124.21K shares derived: sum of 2 quarters · filed 2022-11-09 | 6.65K shares 10-Q · filed 2022-11-09 | 265.87K shares 10-Q · filed 2021-11-15 | 6.65K shares derived: sum of 4 quarters · filed 2022-11-09 | ||
| 2021-06-30 | 19.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | 150.37K shares 10-Q · filed 2022-08-12 | 150.37K shares derived: sum of 3 quarters · filed 2022-08-12 | 150.37K shares derived: sum of 4 quarters · filed 2022-08-12 | |||
| 2021-03-31 | 130.87K shares 10-Q · filed 2021-05-12 | 130.87K shares derived: sum of 2 quarters · filed 2022-07-07 | 130.87K shares derived: sum of 3 quarters · filed 2022-07-07 | 224.03K shares derived: sum of 4 quarters · filed 2022-07-07 | |||
| 2020-12-31 | 0.00 shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-07 | 0.00 shares derived: sum of 2 quarters · filed 2022-07-07 | 93.17K shares derived: sum of 3 quarters · filed 2022-07-07 | 93.17K shares 10-K/A · filed 2022-07-07 | |||
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | 93.17K shares derived: sum of 2 quarters · filed 2021-11-15 | 93.17K shares 10-Q · filed 2021-11-15 | 168.83K shares derived: sum of 4 quarters · filed 2021-11-15 | |||
| 2020-06-30 | 93.17K shares 10-Q · filed 2021-08-12 | 93.17K shares 10-Q · filed 2020-08-06 | 168.83K shares derived: sum of 3 quarters · filed 2021-08-12 | 168.83K shares derived: sum of 4 quarters · filed 2021-08-12 | |||
| 2020-03-31 | 75.67K shares 10-Q · filed 2021-05-12 | 75.67K shares derived: sum of 2 quarters · filed 2021-05-12 | 75.67K shares derived: sum of 3 quarters · filed 2021-05-12 | 75.67K shares derived: sum of 4 quarters · filed 2021-05-12 | |||
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | 0.00 shares derived: sum of 2 quarters · filed 2021-03-25 | 0.00 shares derived: sum of 3 quarters · filed 2021-03-25 | 49.99K shares 10-K · filed 2021-03-25 | |||
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | 0.00 shares derived: sum of 2 quarters · filed 2020-11-09 | 49.99K shares 10-Q · filed 2020-11-09 | 49.99K shares derived: sum of 4 quarters · filed 2020-11-09 | |||
| 2019-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | 49.99K shares 10-Q · filed 2020-08-06 | 750.00K shares 10-Q · filed 2019-08-08 | 49.99K shares derived: sum of 3 quarters · filed 2020-08-06 | -197.82K shares derived: sum of 4 quarters · filed 2020-08-06 | ||
| 2019-03-31 | 49.99K shares 10-Q · filed 2020-05-06 | 49.99K shares derived: sum of 2 quarters · filed 2020-05-06 | -197.82K shares derived: sum of 3 quarters · filed 2020-05-06 | ||||
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | -247.81K shares derived: sum of 2 quarters · filed 2020-03-04 | 27.69K shares 10-K · filed 2020-03-04 | ||||
| 2018-09-30 | -247.81K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 27.69K shares 10-Q · filed 2019-11-07 | |||||
| 2018-06-30 | 275.50K shares 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |